Viewing Study NCT05592756


Ignite Creation Date: 2025-12-24 @ 11:35 PM
Ignite Modification Date: 2026-05-17 @ 9:28 AM
Study NCT ID: NCT05592756
Status: COMPLETED
Last Update Posted: 2023-06-13
First Post: 2022-10-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Secondary Attack Rate Measles Vaccine In Second Situation Contacts Cases Confirmed
Sponsor: The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Measles View
Keywords:

Keywords

Keyword Brief Keyword Text View
None soroprotegido View